Asthma Management Products Market Report – Research, Industry Analysis Reports and Market Demands

Global (United States, European Union and China) Asthma Management Products Market Research Report 2019-2025

Request for Sample of this report

Buy now

Table of Content

1 Report Overview

1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
- 1.3.1 Global Asthma Management Products Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Corticosteroids
- 1.3.3 Bronchodilators
- 1.3.4 Others
1.4 Market Segment by Application
- 1.4.1 Global Asthma Management Products Market Share by Application (2019-2025)
- 1.4.2 Hospital Pharmacy
- 1.4.3 Retail Pharmacy
- 1.4.4 Drug Stores
- 1.4.5 Online Pharmacy
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends

2.1 Global Asthma Management Products Market Size
- 2.1.1 Global Asthma Management Products Revenue 2014-2025
- 2.1.2 Global Asthma Management Products Sales 2014-2025
2.2 Asthma Management Products Growth Rate by Regions
- 2.2.1 Global Asthma Management Products Sales by Regions 2014-2019
- 2.2.2 Global Asthma Management Products Revenue by Regions 2014-2019
2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers

3 Market Share by Manufacturers

3.1 Asthma Management Products Sales by Manufacturers
- 3.1.1 Asthma Management Products Sales by Manufacturers 2014-2019
- 3.1.2 Asthma Management Products Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
- 3.2.1 Asthma Management Products Revenue by Manufacturers (2014-2019)
- 3.2.2 Asthma Management Products Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Asthma Management Products Market Concentration Ratio (CR5 and HHI)
3.3 Asthma Management Products Price by Manufacturers
3.4 Key Manufacturers Asthma Management Products Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Asthma Management Products Market
3.6 Key Manufacturers Asthma Management Products Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Sales and Revenue for Each Type
- 4.1.1 Corticosteroids Sales and Revenue (2014-2019)
- 4.1.2 Bronchodilators Sales and Revenue (2014-2019)
- 4.1.3 Others Sales and Revenue (2014-2019)
4.2 Global Asthma Management Products Sales Market Share by Type
4.3 Global Asthma Management Products Revenue Market Share by Type
4.4 Asthma Management Products Price by Type

5 Market Size by Application

5.1 Overview
5.2 Global Asthma Management Products Sales by Application

6 United States

6.1 United States Asthma Management Products Breakdown Data by Company
6.2 United States Asthma Management Products Breakdown Data by Type
6.3 United States Asthma Management Products Breakdown Data by Application

7 European Union

7.1 European Union Asthma Management Products Breakdown Data by Company
7.2 European Union Asthma Management Products Breakdown Data by Type
7.3 European Union Asthma Management Products Breakdown Data by Application

8 China

8.1 China Asthma Management Products Breakdown Data by Company
8.2 China Asthma Management Products Breakdown Data by Type
8.3 China Asthma Management Products Breakdown Data by Application

9 Rest of World

9.1 Rest of World Asthma Management Products Breakdown Data by Company
9.2 Rest of World Asthma Management Products Breakdown Data by Type
9.3 Rest of World Asthma Management Products Breakdown Data by Application
9.4 Rest of World Asthma Management Products Breakdown Data by Countries
- 9.4.1 Rest of World Asthma Management Products Sales by Countries
- 9.4.2 Rest of World Asthma Management Products Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia

10 Company Profiles

11 Value Chain and Sales Channels Analysis

11.1 Value Chain Analysis
11.2 Sales Channels Analysis
- 11.2.1 Asthma Management Products Sales Channels
- 11.2.2 Asthma Management Products Distributors
11.3 Asthma Management Products Customers

12 Market Forecast

12.1 Global Asthma Management Products Sales and Revenue Forecast 2019-2025
12.2 Global Asthma Management Products Sales Forecast by Type
12.3 Global Asthma Management Products Sales Forecast by Application
12.4 Asthma Management Products Forecast by Regions
- 12.4.1 Global Asthma Management Products Sales Forecast by Regions 2019-2025
- 12.4.2 Global Asthma Management Products Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
  - 14.1.1.1 Research Programs/Design
  - 14.1.1.2 Market Size Estimation
  - 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
  - 14.1.2.1 Secondary Sources
  - 14.1.2.2 Primary Sources
14.2 Author Details

Description

Asthma is a chronic disease, which cannot be cured only appropriate management is possible to control the disease. Asthma targets airways of the lungs causing it to inflame, swallow and tightens the airway of the lungs, causing respiratory tract infection and causing symptoms such as coughing, shortness of breath, tightness, and wheezing. The symptoms of the asthma are related to physical activity, even healthy people suffer from asthma symptoms during vigorous exercise. This type of asthma is called exercise-induced bronchoconstriction (EIB). This type of asthma is controlled and the symptoms are kept under control by developing a management plan by a physician. People with family history of asthma are more prone to this illness and develop allergies frequently. This type of asthma is called allergic asthma. The allergies/asthma due to toxic fumes, gases, dust during the occupation/work in known as occupational asthma. Childhood asthma effects millions of children and is developed in mainly during first five years of life.
Asthma is diagnosed by looking after patient medical history and performing breathing tests, this test helps to measure the amount of air the lungs can hold and examines asthma severity. The medication to manage asthma symptoms are taken daily and contains inhaled corticosteroids such as ciclesonide, budesonide, flunisolide and others. Short acting beta agonist are prescribed for quick relief. The inhaler contains beta blockers and inhaled corticosteroid. Leukotriene modifiers are prescribed for asthma as oral medication. The people suffering from symptoms suffer from respiratory infections such as influenza and pneumonia.
Increasing incidence of respiratory diseases, demand for cost effective medication, as the cost for asthma medication is very high in U.S market. New drug development and approvals, uptake of novel biologic agents, strong brand loyalty, no replacement of inhaler devices, the rise in geriatric population, rise in initiatives implemented by the government and other non-government organizations.
In 2019, the market size of Asthma Management Products is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Asthma Management Products.

This report studies the global market size of Asthma Management Products, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Asthma Management Products sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Teva Pharmaceutical Industries
AstraZeneca
Boehringer Ingelheim
F. Hoffmann-La Roche
GE Healthcare
Merck
Baxter
GlaxoSmithKline
Sanofi-Aventis
Novartis

Market Segment by Product Type
Corticosteroids
Bronchodilators
Others

Market Segment by Application
Hospital Pharmacy
Retail Pharmacy
Drug Stores
Online Pharmacy

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Asthma Management Products status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Asthma Management Products manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Asthma Management Products are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025